Dennis Boyd

Title: Dennis Boyd - Innovator in Pharmaceutical Dosage Forms

Introduction

Dennis Boyd is a notable inventor based in Neshanic Station, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the effectiveness and stability of pharmaceutical products.

Latest Patents

Dennis Boyd holds a patent for a tablet containing an enzymatically converted starch derivative. This invention is directed to a pharmaceutical dosage form that includes an encapsulating agent made from modified starch. The starch is prepared through enzymatic hydrolysis, allowing for improved compressibility and hardness in pharmaceutical tablets. This innovative approach enables high load and retention of various active agents while providing oxidative resistance.

Career Highlights

Dennis Boyd has dedicated his career to advancing pharmaceutical technologies. He is currently associated with National Starch and Chemical Investment Holding Corporation, where he continues to innovate in the field. His work has been instrumental in developing formulations that enhance the delivery and efficacy of medications.

Collaborations

Dennis has collaborated with various professionals in his field, including his coworker Paul Trubiano. These collaborations have contributed to the successful development of his patented technologies.

Conclusion

Dennis Boyd's contributions to pharmaceutical dosage forms demonstrate his commitment to innovation in the industry. His patented work on enzymatically converted starch derivatives showcases the potential for improved pharmaceutical formulations.